Global Non-animal Softgel Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 04 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.

Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.

According to our (Global Info Research) latest study, the global Non-animal Softgel Capsules market size was valued at USD 569 million in 2022 and is forecast to a readjusted size of USD 907.2 million by 2029 with a CAGR of 6.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.

Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.

Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.

This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.

This report is a detailed and comprehensive analysis for global Non-animal Softgel Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Non-animal Softgel Capsules market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/K Pcs), 2018-2029
Global Non-animal Softgel Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/K Pcs), 2018-2029
Global Non-animal Softgel Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/K Pcs), 2018-2029
Global Non-animal Softgel Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (USD/K Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-animal Softgel Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-animal Softgel Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Capsugel, Amway, Patheon, Catalent and Procaps Laboratorios, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Non-animal Softgel Capsules market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Starches
    Pullulan
    Other

Market segment by Application
    Pharmaceutical
    Health Supplements
    Others

Major players covered
    Capsugel
    Amway
    Patheon
    Catalent
    Procaps Laboratorios
    Eurocaps
    Best Formulations
    Aenova
    Captek
    SIRIO
    Bahrain Pharma
    Robinson Pharma

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-animal Softgel Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-animal Softgel Capsules, with price, sales, revenue and global market share of Non-animal Softgel Capsules from 2018 to 2023.
Chapter 3, the Non-animal Softgel Capsules competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-animal Softgel Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-animal Softgel Capsules market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-animal Softgel Capsules.
Chapter 14 and 15, to describe Non-animal Softgel Capsules sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Non-animal Softgel Capsules
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Non-animal Softgel Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Starches
        1.3.3 Pullulan
        1.3.4 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Non-animal Softgel Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical
        1.4.3 Health Supplements
        1.4.4 Others
    1.5 Global Non-animal Softgel Capsules Market Size & Forecast
        1.5.1 Global Non-animal Softgel Capsules Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Non-animal Softgel Capsules Sales Quantity (2018-2029)
        1.5.3 Global Non-animal Softgel Capsules Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Capsugel
        2.1.1 Capsugel Details
        2.1.2 Capsugel Major Business
        2.1.3 Capsugel Non-animal Softgel Capsules Product and Services
        2.1.4 Capsugel Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Capsugel Recent Developments/Updates
    2.2 Amway
        2.2.1 Amway Details
        2.2.2 Amway Major Business
        2.2.3 Amway Non-animal Softgel Capsules Product and Services
        2.2.4 Amway Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Amway Recent Developments/Updates
    2.3 Patheon
        2.3.1 Patheon Details
        2.3.2 Patheon Major Business
        2.3.3 Patheon Non-animal Softgel Capsules Product and Services
        2.3.4 Patheon Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Patheon Recent Developments/Updates
    2.4 Catalent
        2.4.1 Catalent Details
        2.4.2 Catalent Major Business
        2.4.3 Catalent Non-animal Softgel Capsules Product and Services
        2.4.4 Catalent Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Catalent Recent Developments/Updates
    2.5 Procaps Laboratorios
        2.5.1 Procaps Laboratorios Details
        2.5.2 Procaps Laboratorios Major Business
        2.5.3 Procaps Laboratorios Non-animal Softgel Capsules Product and Services
        2.5.4 Procaps Laboratorios Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Procaps Laboratorios Recent Developments/Updates
    2.6 Eurocaps
        2.6.1 Eurocaps Details
        2.6.2 Eurocaps Major Business
        2.6.3 Eurocaps Non-animal Softgel Capsules Product and Services
        2.6.4 Eurocaps Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Eurocaps Recent Developments/Updates
    2.7 Best Formulations
        2.7.1 Best Formulations Details
        2.7.2 Best Formulations Major Business
        2.7.3 Best Formulations Non-animal Softgel Capsules Product and Services
        2.7.4 Best Formulations Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Best Formulations Recent Developments/Updates
    2.8 Aenova
        2.8.1 Aenova Details
        2.8.2 Aenova Major Business
        2.8.3 Aenova Non-animal Softgel Capsules Product and Services
        2.8.4 Aenova Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Aenova Recent Developments/Updates
    2.9 Captek
        2.9.1 Captek Details
        2.9.2 Captek Major Business
        2.9.3 Captek Non-animal Softgel Capsules Product and Services
        2.9.4 Captek Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Captek Recent Developments/Updates
    2.10 SIRIO
        2.10.1 SIRIO Details
        2.10.2 SIRIO Major Business
        2.10.3 SIRIO Non-animal Softgel Capsules Product and Services
        2.10.4 SIRIO Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 SIRIO Recent Developments/Updates
    2.11 Bahrain Pharma
        2.11.1 Bahrain Pharma Details
        2.11.2 Bahrain Pharma Major Business
        2.11.3 Bahrain Pharma Non-animal Softgel Capsules Product and Services
        2.11.4 Bahrain Pharma Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Bahrain Pharma Recent Developments/Updates
    2.12 Robinson Pharma
        2.12.1 Robinson Pharma Details
        2.12.2 Robinson Pharma Major Business
        2.12.3 Robinson Pharma Non-animal Softgel Capsules Product and Services
        2.12.4 Robinson Pharma Non-animal Softgel Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Robinson Pharma Recent Developments/Updates

3 Competitive Environment: Non-animal Softgel Capsules by Manufacturer
    3.1 Global Non-animal Softgel Capsules Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Non-animal Softgel Capsules Revenue by Manufacturer (2018-2023)
    3.3 Global Non-animal Softgel Capsules Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Non-animal Softgel Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Non-animal Softgel Capsules Manufacturer Market Share in 2022
        3.4.2 Top 6 Non-animal Softgel Capsules Manufacturer Market Share in 2022
    3.5 Non-animal Softgel Capsules Market: Overall Company Footprint Analysis
        3.5.1 Non-animal Softgel Capsules Market: Region Footprint
        3.5.2 Non-animal Softgel Capsules Market: Company Product Type Footprint
        3.5.3 Non-animal Softgel Capsules Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Non-animal Softgel Capsules Market Size by Region
        4.1.1 Global Non-animal Softgel Capsules Sales Quantity by Region (2018-2029)
        4.1.2 Global Non-animal Softgel Capsules Consumption Value by Region (2018-2029)
        4.1.3 Global Non-animal Softgel Capsules Average Price by Region (2018-2029)
    4.2 North America Non-animal Softgel Capsules Consumption Value (2018-2029)
    4.3 Europe Non-animal Softgel Capsules Consumption Value (2018-2029)
    4.4 Asia-Pacific Non-animal Softgel Capsules Consumption Value (2018-2029)
    4.5 South America Non-animal Softgel Capsules Consumption Value (2018-2029)
    4.6 Middle East and Africa Non-animal Softgel Capsules Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    5.2 Global Non-animal Softgel Capsules Consumption Value by Type (2018-2029)
    5.3 Global Non-animal Softgel Capsules Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    6.2 Global Non-animal Softgel Capsules Consumption Value by Application (2018-2029)
    6.3 Global Non-animal Softgel Capsules Average Price by Application (2018-2029)

7 North America
    7.1 North America Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    7.2 North America Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    7.3 North America Non-animal Softgel Capsules Market Size by Country
        7.3.1 North America Non-animal Softgel Capsules Sales Quantity by Country (2018-2029)
        7.3.2 North America Non-animal Softgel Capsules Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    8.2 Europe Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    8.3 Europe Non-animal Softgel Capsules Market Size by Country
        8.3.1 Europe Non-animal Softgel Capsules Sales Quantity by Country (2018-2029)
        8.3.2 Europe Non-animal Softgel Capsules Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Non-animal Softgel Capsules Market Size by Region
        9.3.1 Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Non-animal Softgel Capsules Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    10.2 South America Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    10.3 South America Non-animal Softgel Capsules Market Size by Country
        10.3.1 South America Non-animal Softgel Capsules Sales Quantity by Country (2018-2029)
        10.3.2 South America Non-animal Softgel Capsules Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Non-animal Softgel Capsules Market Size by Country
        11.3.1 Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Non-animal Softgel Capsules Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Non-animal Softgel Capsules Market Drivers
    12.2 Non-animal Softgel Capsules Market Restraints
    12.3 Non-animal Softgel Capsules Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Non-animal Softgel Capsules and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Non-animal Softgel Capsules
    13.3 Non-animal Softgel Capsules Production Process
    13.4 Non-animal Softgel Capsules Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Non-animal Softgel Capsules Typical Distributors
    14.3 Non-animal Softgel Capsules Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Non-animal Softgel Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Non-animal Softgel Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Capsugel Basic Information, Manufacturing Base and Competitors
    Table 4. Capsugel Major Business
    Table 5. Capsugel Non-animal Softgel Capsules Product and Services
    Table 6. Capsugel Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Capsugel Recent Developments/Updates
    Table 8. Amway Basic Information, Manufacturing Base and Competitors
    Table 9. Amway Major Business
    Table 10. Amway Non-animal Softgel Capsules Product and Services
    Table 11. Amway Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Amway Recent Developments/Updates
    Table 13. Patheon Basic Information, Manufacturing Base and Competitors
    Table 14. Patheon Major Business
    Table 15. Patheon Non-animal Softgel Capsules Product and Services
    Table 16. Patheon Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Patheon Recent Developments/Updates
    Table 18. Catalent Basic Information, Manufacturing Base and Competitors
    Table 19. Catalent Major Business
    Table 20. Catalent Non-animal Softgel Capsules Product and Services
    Table 21. Catalent Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Catalent Recent Developments/Updates
    Table 23. Procaps Laboratorios Basic Information, Manufacturing Base and Competitors
    Table 24. Procaps Laboratorios Major Business
    Table 25. Procaps Laboratorios Non-animal Softgel Capsules Product and Services
    Table 26. Procaps Laboratorios Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Procaps Laboratorios Recent Developments/Updates
    Table 28. Eurocaps Basic Information, Manufacturing Base and Competitors
    Table 29. Eurocaps Major Business
    Table 30. Eurocaps Non-animal Softgel Capsules Product and Services
    Table 31. Eurocaps Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Eurocaps Recent Developments/Updates
    Table 33. Best Formulations Basic Information, Manufacturing Base and Competitors
    Table 34. Best Formulations Major Business
    Table 35. Best Formulations Non-animal Softgel Capsules Product and Services
    Table 36. Best Formulations Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Best Formulations Recent Developments/Updates
    Table 38. Aenova Basic Information, Manufacturing Base and Competitors
    Table 39. Aenova Major Business
    Table 40. Aenova Non-animal Softgel Capsules Product and Services
    Table 41. Aenova Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Aenova Recent Developments/Updates
    Table 43. Captek Basic Information, Manufacturing Base and Competitors
    Table 44. Captek Major Business
    Table 45. Captek Non-animal Softgel Capsules Product and Services
    Table 46. Captek Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Captek Recent Developments/Updates
    Table 48. SIRIO Basic Information, Manufacturing Base and Competitors
    Table 49. SIRIO Major Business
    Table 50. SIRIO Non-animal Softgel Capsules Product and Services
    Table 51. SIRIO Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. SIRIO Recent Developments/Updates
    Table 53. Bahrain Pharma Basic Information, Manufacturing Base and Competitors
    Table 54. Bahrain Pharma Major Business
    Table 55. Bahrain Pharma Non-animal Softgel Capsules Product and Services
    Table 56. Bahrain Pharma Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Bahrain Pharma Recent Developments/Updates
    Table 58. Robinson Pharma Basic Information, Manufacturing Base and Competitors
    Table 59. Robinson Pharma Major Business
    Table 60. Robinson Pharma Non-animal Softgel Capsules Product and Services
    Table 61. Robinson Pharma Non-animal Softgel Capsules Sales Quantity (M Pcs), Average Price (USD/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Robinson Pharma Recent Developments/Updates
    Table 63. Global Non-animal Softgel Capsules Sales Quantity by Manufacturer (2018-2023) & (M Pcs)
    Table 64. Global Non-animal Softgel Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Non-animal Softgel Capsules Average Price by Manufacturer (2018-2023) & (USD/K Pcs)
    Table 66. Market Position of Manufacturers in Non-animal Softgel Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Non-animal Softgel Capsules Production Site of Key Manufacturer
    Table 68. Non-animal Softgel Capsules Market: Company Product Type Footprint
    Table 69. Non-animal Softgel Capsules Market: Company Product Application Footprint
    Table 70. Non-animal Softgel Capsules New Market Entrants and Barriers to Market Entry
    Table 71. Non-animal Softgel Capsules Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Non-animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Pcs)
    Table 73. Global Non-animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Pcs)
    Table 74. Global Non-animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Non-animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Non-animal Softgel Capsules Average Price by Region (2018-2023) & (USD/K Pcs)
    Table 77. Global Non-animal Softgel Capsules Average Price by Region (2024-2029) & (USD/K Pcs)
    Table 78. Global Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 79. Global Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 80. Global Non-animal Softgel Capsules Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Non-animal Softgel Capsules Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Non-animal Softgel Capsules Average Price by Type (2018-2023) & (USD/K Pcs)
    Table 83. Global Non-animal Softgel Capsules Average Price by Type (2024-2029) & (USD/K Pcs)
    Table 84. Global Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 85. Global Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 86. Global Non-animal Softgel Capsules Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Non-animal Softgel Capsules Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Non-animal Softgel Capsules Average Price by Application (2018-2023) & (USD/K Pcs)
    Table 89. Global Non-animal Softgel Capsules Average Price by Application (2024-2029) & (USD/K Pcs)
    Table 90. North America Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 91. North America Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 92. North America Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 93. North America Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 94. North America Non-animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Pcs)
    Table 95. North America Non-animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Pcs)
    Table 96. North America Non-animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Non-animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 99. Europe Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 100. Europe Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 101. Europe Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 102. Europe Non-animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Pcs)
    Table 103. Europe Non-animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Pcs)
    Table 104. Europe Non-animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Non-animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 107. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 108. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 109. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 110. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Pcs)
    Table 111. Asia-Pacific Non-animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Pcs)
    Table 112. Asia-Pacific Non-animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Non-animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 115. South America Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 116. South America Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 117. South America Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 118. South America Non-animal Softgel Capsules Sales Quantity by Country (2018-2023) & (M Pcs)
    Table 119. South America Non-animal Softgel Capsules Sales Quantity by Country (2024-2029) & (M Pcs)
    Table 120. South America Non-animal Softgel Capsules Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Non-animal Softgel Capsules Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Type (2018-2023) & (M Pcs)
    Table 123. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Type (2024-2029) & (M Pcs)
    Table 124. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Application (2018-2023) & (M Pcs)
    Table 125. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Application (2024-2029) & (M Pcs)
    Table 126. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Region (2018-2023) & (M Pcs)
    Table 127. Middle East & Africa Non-animal Softgel Capsules Sales Quantity by Region (2024-2029) & (M Pcs)
    Table 128. Middle East & Africa Non-animal Softgel Capsules Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Non-animal Softgel Capsules Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Non-animal Softgel Capsules Raw Material
    Table 131. Key Manufacturers of Non-animal Softgel Capsules Raw Materials
    Table 132. Non-animal Softgel Capsules Typical Distributors
    Table 133. Non-animal Softgel Capsules Typical Customers
List of Figures
    Figure 1. Non-animal Softgel Capsules Picture
    Figure 2. Global Non-animal Softgel Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Non-animal Softgel Capsules Consumption Value Market Share by Type in 2022
    Figure 4. Starches Examples
    Figure 5. Pullulan Examples
    Figure 6. Other Examples
    Figure 7. Global Non-animal Softgel Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Non-animal Softgel Capsules Consumption Value Market Share by Application in 2022
    Figure 9. Pharmaceutical Examples
    Figure 10. Health Supplements Examples
    Figure 11. Others Examples
    Figure 12. Global Non-animal Softgel Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Non-animal Softgel Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Non-animal Softgel Capsules Sales Quantity (2018-2029) & (M Pcs)
    Figure 15. Global Non-animal Softgel Capsules Average Price (2018-2029) & (USD/K Pcs)
    Figure 16. Global Non-animal Softgel Capsules Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Non-animal Softgel Capsules Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Non-animal Softgel Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Non-animal Softgel Capsules Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Non-animal Softgel Capsules Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Non-animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Non-animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Non-animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Non-animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Non-animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Non-animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Non-animal Softgel Capsules Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Non-animal Softgel Capsules Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Non-animal Softgel Capsules Average Price by Type (2018-2029) & (USD/K Pcs)
    Figure 31. Global Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Non-animal Softgel Capsules Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Non-animal Softgel Capsules Average Price by Application (2018-2029) & (USD/K Pcs)
    Figure 34. North America Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Non-animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Non-animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Non-animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Non-animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Non-animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Non-animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Non-animal Softgel Capsules Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Non-animal Softgel Capsules Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Non-animal Softgel Capsules Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Non-animal Softgel Capsules Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Non-animal Softgel Capsules Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Non-animal Softgel Capsules Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Non-animal Softgel Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Non-animal Softgel Capsules Market Drivers
    Figure 75. Non-animal Softgel Capsules Market Restraints
    Figure 76. Non-animal Softgel Capsules Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Non-animal Softgel Capsules in 2022
    Figure 79. Manufacturing Process Analysis of Non-animal Softgel Capsules
    Figure 80. Non-animal Softgel Capsules Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Capsugel
Amway
Patheon
Catalent
Procaps Laboratorios
Eurocaps
Best Formulations
Aenova
Captek
SIRIO
Bahrain Pharma
Robinson Pharma

Related Reports

Global Non-Animal Softgel Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Global Non-animal Softgel Capsules Supply, Demand and Key Producers, 2023-2029

Global Non-animal Softgel Capsules Supply, Demand and Key Producers, 2023-2029

date 04 Mar 2023

date Pharma & Healthcare

Global Non-Animal Softgel Capsules Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Non-Animal Softgel Capsules Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Sep 2024

date Pharma & Healthcare

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.

Global Non-animal Softgel Capsules Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Non-animal Softgel Capsules market size was valued at USD 569 million in 2023 and is forecast to a readjusted size of USD 907.2 million by 2030 with a CAGR of 6.9% during review period.

Global Non-Animal Softgel Capsules Supply, Demand and Key Producers, 2024-2030

Global Non-Animal Softgel Capsules Supply, Demand and Key Producers, 2024-2030

date 09 Sep 2024

date Pharma & Healthcare

Product Tags

Non-Animal Softgel Capsules

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>